Luis Fayad

Proud to share that I have been promoted to Professor at @MDAndersonNews. I am profoundly grateful for my patients, team, colleagues, collaborators, and mentors. Looking forward to the next steps to #EndCancer

@ProfHoax__ @Catmeow82502520 es decir q no era ud el cantinflas

@ProfHoax__ @Catmeow82502520 profe se equivocó no era a ud lo aludido

Chemo-free combination of ponatinib + blinatumomab is potentially curative in Ph+ ALL w/o need for intensive chemo or allo-SCT. This is new standard of care in Ph+ ALL. Jabbour, Short, Kantarjian of @MDAndersonNews #Leukemia authors.elsevier.com/a/1g5k18MsWYC4… via @TheLancetHaem #leusm

NOW OF: In a single-centre, single-arm, ph 2 trial, 33 (87%) of 38 patients with ND and 11 (79%) of 13 with R/R Ph-positive ALL and 2 (33%) of 6 patients with blast-phase CML had a complete molecular response with ponatinib and blinatumomab. #leusm thelancet.com/journals/lanha…

TP53 mut #MDS/#AML: Biology, Current Therapy, and Future Directions - state of the art review in @CD_AACR by @MDAndersonNews #Leukemia Naval Daver, MD, @Daver_Leukemia and Abhi Maiti, MD t.ly/MIxP #leusm

Desmoid tumors are often misunderstood and misdiagnosed. Learn more with this video introduction and visit our educational website.

Indeed, we are #1 because of a deeply shared commitment to teamwork, 5 core values, and an unending quest to #endcancer. #UTinServicetoTexas

We are proud to announce the MD Anderson Lymphoma & Myeloma Fellowship program, better than ever. If you are interested, see details here: mdanderson.org/education-trai…

@GuiperiniMD @MDAndersonNews @bpromd @DrNathanFowler @michaelwangmd congratulations Guilherme!!

12 years ago I was at #ASCO22 to present some posters from my time at @MDAndersonNews, guided by my mentors @bpromd @DrNathanFowler and @lefayad. This year I come back as one of the authors of the SHINE trial, Just presented by @michaelwangmd. What an improbable journey...

@darwinjulian21 @Catmeow82502520 @yankisitoFit @Cupsfire_gye bueno yo creo que conocía a mi sobrino mas que ud, y existe algo que se llama empatía y no prejuzgar, ojalá nunca pase x una tragedia así y aparezca un experto igual a ud

@Catmeow82502520 @yankisitoFit @Cupsfire_gye Lastima x lo sucedido, pero lo dudo, no creo q este joven haga algo chueco y tenga q decírselo a su familia. X eso en todos los casos se dice lo mismo. Trabajador, honrado y sin orobrlmas con nadie 🤷🏻‍♂️

🚨 #ULTIMAHORA: Se registra un nuevo caso de sicariato en el Malecon turístico del Buijo Histórico en Samborondon. 👮‍♂️🚔 Personal de Policía Nacional acude al punto para tomar procedimiento.

Calling on all @ASCO members! This is an easy but important task that takes a minute to do: click below to help us #FixPriorAuth

⁦@Lymphoma_Doc⁩ outlining the role of CAR-T in DLBCL. ⁦@lymphomahub⁩ ⁦@MDAndersonNews⁩ ⁦@sairah__ahmed⁩

Outstanding talk by ⁦@sairah__ahmed⁩ on #hodgkinslymphoma -nuances of choosing the right treatment with novel agents, #CAR-T. ⁦@MDAndersonNews⁩ ⁦@Lymphoma_Doc⁩ ⁦@michaelwangmd⁩

👩‍🔬👨‍🔬 @MDAndersonNews scientists including Drs. Jason Westin and Michael Green conducted a Risk assessment with low pass whole genome sequencing of cell-free DNA before CD19 CAR T cells for large #BCellLymphoma. bit.ly/3KOK6D1

The latest Lymphoma Daily! paper.li/Lymphoma_Doc/1… Thanks to @TheHourNews @LLSusa @Patient_Story #hodgkinslymphoma #cancer

Faculty positions available for #myeloma clinician scientists. Join our @MDAndersonNews #Myeloma Team! mdanderson.org/about-md-ander… Please RT!

@Victorivaden @opcionsecuador @CarlaMaldonadoP @sybelmartinez @AlbertoAcostaE @ACampanaRemache @radio_pichincha @LoloMino @karengsherdek @cahuasquic fluctuates cerca de mi casa en kroger que no es la mas cara la regular 3.71 y la premium 4.31 pero costco es mas barato

Indignante ECUADOR 🇪🇨 Hoy día: En EEUU, en Houston-Texas, el galón de gasolina premium (93 octanos) está en $3,85 Acá, que el petróleo nos "pertenece a todos los ecuatorianos", país petrolero, el galón de super (92 octanos) está en $4,70 Hasta cuándo nos siguen robando 🤬

Faculty positions available for #myeloma clinician scientists. Join our @MDAndersonNews #Myeloma Team! mdanderson.org/about-md-ander… Please RT!

Thank you to @asco for naming me an Advocacy Champion at the #ASCOAdvocacySUmmit. I’m proud to fight for our patients, for increased funding for @NIH, @theNCI, & #CancerMoonshot, and more.